<?xml version="1.0" encoding="UTF-8"?>
<ref id="B204-vaccines-08-00468">
 <label>204.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Veale</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Torley</surname>
    <given-names>H.I.</given-names>
   </name>
   <name>
    <surname>Richards</surname>
    <given-names>I.M.</given-names>
   </name>
   <name>
    <surname>Oâ€™Dowd</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Fitzsimons</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Belch</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Sturrock</surname>
    <given-names>R.D.</given-names>
   </name>
  </person-group>
  <article-title>A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis</article-title>
  <source>Br. J. Rheumatol.</source>
  <year>1994</year>
  <volume>33</volume>
  <fpage>954</fpage>
  <lpage>958</lpage>
  <pub-id pub-id-type="doi">10.1093/rheumatology/33.10.954</pub-id>
  <pub-id pub-id-type="pmid">7921757</pub-id>
 </element-citation>
</ref>
